| Waldhoer, Maria (InterAx Biotech 201804 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
InterAx Biotech AG |
Switzerland |
| Waldmann, Herbert (MPI für molekulare Physiologie 200503) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Waldmann, Thomas (Proteros 201110 Director Business Development before Sloning 200607–201108– BusDev Manager) |
Business Development Manager / Strategy Manager |
Proteros (Group) |
Germany |
| Walek, Josef (Baden-Württemberg (govt) 202407 Investment Manager at MBG) |
Investment Manager |
Baden-Württemberg (govt region) |
Germany |
| Wales, Martin (UBS 200809 Analyst) |
Analyst (Financial / Industry) |
UBS (Group) |
Switzerland |
| Walger, Martin (VDGH 202001 Managing Director) |
Managing Director |
VDGH (Verband der Diagnostica-Industrie e. V.) |
Germany |
| Walkenhorst, Jürgen (Hamburg (govt) 202206–202312 Managing Director of Life Science Nord before PROvendis RESIGNED) |
Cluster Manager |
Hamburg (govt region) |
Germany |
| Walker, Adam (Informa 201307 Finance Director) |
Chief Financial Officer (CFO) |
Informa (Group) [NEW] |
Switzerland |
| Walker, Anthony (Alacrita 2009– Founding Partner before Onyvax CEO + co-founder before consultant) |
Company Founder |
Alacrita (Group) |
United Kingdom (GB) |
| Walker, Oliver (Evolva 201807–202202 CEO before CFO before Sivantos + Nobel Biocare + Sonova + Stratec) |
Chief Executive Officer (CEO) |
Lallemand (Group) |
Switzerland |
| Wall, Brian (Calibre Scientific 202303 Executive Chair + Founder plus CEO + Founder of StoneCalibre) |
Board member, executive |
Calibre Scientific (Group) |
United States (USA) |
| Wallace, Wallace (Univ Oxford 202203– Associate LS at Oxford Science Enterprises before M Ventures + Accenture) |
venture capital |
Oxford Science Enterprises (Group) |
United Kingdom (GB) |
| Wallasch, Christian (Atriva Therapeutics 201901 COO before Axxima + U3 + Intercell/Valneva) |
Chief Operating Officer (COO) |
Atriva Therapeutics GmbH |
Germany |
| Walldén, Erik (Gyros 200903–201310 CEO RESIGNED 10/13 before Affibody CEO + Biacore CEO + Pyrosequencing CEO) |
Chief Executive Officer (CEO) |
Mesa Laboratories (Mesa Labs) (Group) |
Sweden |
| Waller, Ivana (Accovion 201010 COO) |
Chief Operating Officer (COO) |
Clinipace (Group) |
Germany |
| Wallis, Tim (Ridgeway Biologicals 201701 Managing Director) |
Managing Director |
Klocke (Group) |
United Kingdom (GB) |
| Wallnöfer, Andreas (Jeito Capital 202202– Partner Investor before BioMedPartners + Roche) |
Partner (venture partner) |
Jeito Capital (Group) |
France |
| Walrafen, Pierre (Scipio Bioscience 201711 CEO) |
Chief Executive Officer (CEO) |
Scipio Bioscience SAS |
France |
| Walser, Charles (Tanovis 202101 CEO) |
Chief Executive Officer (CEO) |
Tanovis AG |
Switzerland |
| Walser, Rudolf (LTF-Labortechnik 200512) |
Sales Manager / Marketing Manager |
LTF Labortechnik (Group) |
Germany |
| Walsh, Kellie (KWM Communications 2007– Founder) |
Public Relations Manager / Investor Relations Manager |
KWM Communications LLC |
United States (USA) |
| Walsh, Matthew (Organon 202409 CFO) |
Chief Financial Officer (CFO) |
Organon (Group) |
United States (USA) |
| Walsh, Patrick (Immunic 202110– CBO before Akebia Therapeutics + Aveo Oncology + Capgemini + Leerink Partners) |
Chief Business Officer (CBO) |
Immunic (Group) |
United States (USA) |
| Walte, Andreas (Airsense Analytics 200911 Managing Director + Photonion 200911 Managing Director) |
Managing Director |
Airsense Analytics GmbH |
Germany |
| Walter, Jörn (Univ Saarland 201208 Professor + Co-ordinator of German Epigenome Program DEEP) |
Professor |
Saarland University (Universität des Saarlandes) |
Germany |
| Walter, Monika (Hyglos 2010 Manager Operations) |
Chief Operating Officer (COO) |
Mérieux (Group) |
Germany |
| Walther, Hansjörg (Solvias 2003–201402 CEO joined 1999 RETIRED 3/14) |
Chief Executive Officer (CEO) |
Solvias (Group) |
Switzerland |
| Walther, Johannes (IPM AG 2022 CEO) |
Chief Executive Officer (CEO) |
IPM AG – Institut für Produktionsmanagement |
Germany |
| Walz, Stephan (Invent Pharma / Neuraxpharm 201706 CEO) |
Chief Executive Officer (CEO) |
NuPharm (Group) |
Spain (España) |
| Walz-Tylla, Birgitt (Bayer CropSciences 200802 Head Food Chain Management) |
President/Director/Head Business Group/Unit/Division |
Bayer (Group) |
Germany |
| Wambutt, Rolf (AGOWA 200503) |
n. a. |
LGC (Group) |
Germany |
| Wamser, Jörg (ProteoPlex GmbH 201805 Managing Director before KonTEM GmbH 201202 Managing Director) |
Managing Director |
ProteoPlex GmbH |
Germany |
| Wanczek, Karl-Peter (Univ Bremen 1976– Professor for Anorganic Chemistry before Univ Frankfurt/M) |
Professor |
University of Bremen |
Germany |
| Wandeler, Roland (MorphoSys 202005– Chief Commercial Officer before Amgen + Boston Consulting Group) |
Chief Commercial Officer (CCO) |
Novartis (Group) |
Germany |
| Wanderer, Gaby (Xiril 201204 Product Manager) |
Product Manager (personnel) |
Tecan (Group) |
Switzerland |
| Wandersee, Christian (Vasopharm GmbH 201306 Managing Director) |
Managing Director |
Vasopharm GmbH |
Germany |
| Wandrey, Sarah (Minapharm 202202 Corporate Communications at ProBioGen) |
Public Relations Manager / Investor Relations Manager |
Minapharm (Group) |
Germany |
| Wang, Bob (Agena Bioscience 201509– VP + General Manager Greater China before Qiagen + Hologic) |
General Manager (management) |
Agena Bioscience (Group) |
China |
| Wang, Ruizhi (HexagonFab 202412 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
HexagonFab Ltd. (d/b/a Abselion) |
United Kingdom (GB) |
| Wang, Sarah (Sartorius 202109 Head of Sales + Services in China) |
Sales Manager / Marketing Manager |
Sartorius (Group) |
China |
| Wang, Suohui (China National Nuclear 202109 General Manager of CIRC) |
General Manager (management) |
China National Nuclear (Group) |
China |
| Wang, Yingting (Proteona 202003 Director of Development) |
Business Development Manager / Strategy Manager |
Singleron (Group) |
Singapore |
| Wanka, Johanna (Germany (govt) 2013 Minister of Education + Research before Niedersachsen (govt) Minister) |
Minister |
Germany (govt) |
Germany |
| Wanker, Erich |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Wanko, Markus (IST Cube 202107 Managing Partner) |
Managing Partner (investment firm) |
Xista Science Ventures (fomerly IST cube) |
Austria |
| Wanner, Antonia (Nestlé 202012 Head ESG Strategy + Deployment Unit) |
President/Director/Head Business Group/Unit/Division |
Nestlé (Group) |
Switzerland |
| Wanner, Sarah-Christine (Bayer 202003 External Innovation + Partnering) |
n. a. |
Bayer (Group) |
Germany |
| Warburton, Mark (Cyprotex 201608 COO + Legal Counsel) |
Chief Operating Officer (COO) |
Evotec (Group) |
United Kingdom (GB) |
| Ward, Constance (Lonza 201610 Head External Communications) |
Public Relations Manager / Investor Relations Manager |
Lonza (Group) |
Switzerland |
| Ward, Jonathan (Genome Biologics (DE) 201810 CEO) |
Chief Executive Officer (CEO) |
Genome Biologics UG |
Germany |
| Ward, Justin (Bruker 202204 Senior Director IR + Corporate Development) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
| Wardengais, Rainer (Enzymicals 201809– Business Development Manager before Research + Production + Co-Founder) |
Business Development Manager / Strategy Manager |
Enzymicals AG |
Germany |
| Warmuth, Markus (Monte Rosa Therapeutics 202009 CEO + Venture Partner at Versant Ventures before Eisai/H3 Biomedicine) |
Chief Executive Officer (CEO) |
Monte Rosa Therapeutics (Group) |
United States (USA) |
| Warn, Peter (Evotec 201706 SVP Antibiotic Discovery) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Warnack, Boris (BioDGraft 202209 CEO + Co-Founder before Holistick Medical + Xeltis) |
Chief Executive Officer (CEO) |
BioDGraft GmbH |
Austria |
| Warners, Morgan (WPP 201811 at Glover Park Group) |
Public Relations Manager / Investor Relations Manager |
WPP (Group) |
|
| Warnk, Dörthe (Bosch 202404) |
Public Relations Manager / Investor Relations Manager |
Bosch (Group) |
Germany |
| Warnke, Stephan (IsoSpe Analytics 202404 Co-Founder) |
Professor |
EPFL (Ecole Polytechnique Fédérale de Lausanne) |
Switzerland |
| Warren, Chris (LECO 201106 Managing Director of LECO Instrumente GmbH) |
Managing Director |
Leco (Group) |
Germany |
| Wasiak, Radoslaw (Radek) (Cytel 202309 General Manager Real World + Advanced Analytics) |
Managing Director |
Cytel (Group) |
Germany |
| Wasner, Mark (MVZ für Mikrobiologie Dessau 201009) |
Laboratory Manager (industry) |
MVZ für Mikrobiologie, Labordiagnostik und Hygiene Dessau GmbH |
Germany |
| Wass, Ed (Catapult Ventures 201509) |
Investment Manager |
Catapult Ventures (Group) |
United Kingdom (GB) |
| Wassill, Lars (AmplexDiagnostics 200810) |
n. a. |
AmplexDiagnostics GmbH |
Germany |
| Watanabe, Yoshiaki (Rigaku 201906 Senior EVP) |
President/Director/Head Business Group/Unit/Division |
Rigaku (Group) |
Japan |
| Watons, John A. (SomPharmaceuticals SA 201411 CEO) |
Chief Executive Officer (CEO) |
Amryt Pharma (Group) |
Switzerland |
| Watson, Andy (RainDance Technologies 201212 Chief Marketing Officer) |
Sales Manager / Marketing Manager |
Bio-Rad (Group) |
United States (USA) |
| Watson, John (Covance 201205 President Strategic Partnering + Chief Commercial Officer) |
Chief Commercial Officer (CCO) |
LabCorp (Group) |
United States (USA) |
| Watson, Nicola (Schauenburg 201412 at Markes international) |
n. a. |
Schauenburg (Group) |
United Kingdom (GB) |
| Watt, Steven (Labor für Analytik 201009 Business Development A & M StabTest GmbH) |
Business Development Manager / Strategy Manager |
A&M Labor für Analytik (Group) |
Germany |
| Watts, Michael (Hologic 202101 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Hologic (Group) |
United States (USA) |
| Watts, Richard (Qiagen 201004– Director Pharma Business Development before Pharma Regional Marketing Manager) |
Business Development Manager / Strategy Manager |
Qiagen (Group) |
Germany |
| Watts, Ryan (Denali Therapeutics 201608 CEO) |
Chief Executive Officer (CEO) |
Denali Therapeutics (Group) |
United States (USA) |
| Watzke, Harald (MorphoSys 200704 Head Alliance Management) |
Business Development Manager / Strategy Manager |
Novartis (Group) |
Germany |
| Watzke, Herr (Finanzamt Bremen 201405 Umsatzsteuerprüfung) |
n. a. |
Bremen (govt region) |
|
| Watzke, Roland (Amykor GmbH 200810) |
n. a. |
Amykor GmbH |
Germany |
| Waurich-Hähnlein, Kathrin (Comprehensive Biomarker Center GmbH 201201 Marketing Manager) |
Sales Manager / Marketing Manager |
Hummingbird Diagnostics GmbH |
Germany |
| Wawrzinek, Christian (Ethris 202201– Managing Director + Chief Corp Strategy Officer + Co-Founder of Laureus Capital) |
Managing Director |
Ethris GmbH |
Germany |
| Wawrzinek, Kai (Laureus Capital 202201 Co-Founder) |
Company Founder |
Laureus Capital (Christian + Kai Wawrzinek) |
|
| Wawrzinek, Robert (Cutanos 202107 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Cutanos GmbH |
Austria |
| Wax, Martin B. (Alcon 200601 VP RnD + head Ophtalmology Discovery Research) |
Research & Development Manager |
Novartis (Group) |
Switzerland |
| Waxman, Allen (Roivant Sciences 201709– General Counsel before Eisai Inc + Kaye Scholer + Pfizer 2003–200803) |
General Counsel / Chief Legal Officer (CLO) |
Roivant (Group) |
Switzerland |
| Way, Wayne K. (Sigma-Aldrich 2010022 Marketing Manager HPLC-GC) |
Sales Manager / Marketing Manager |
Merck (DE) (Group) |
United States (USA) |
| Weatherall, Jim (AstraZeneca 202110 VP Data Science + Ai, RnD) |
President/Director/Head Business Group/Unit/Division |
AstraZeneca (Group) |
United Kingdom (GB) |
| Weaver, Aaron (Apeiron Investment 202110 Principal) |
Principal (venture capital) |
ANGERMAYER Group (Apeiron Investment Group/Presight Ventures) (family of Christian Angermayer) |
Malta |
| Webb, Andrew (EKF Diagnostics 201303– CEO of EKF Molecular Diagnostics before Qiagen/DxS + Amersham Pharmacia Biotech) |
Chief Executive Officer (CEO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Weber, Albert (Epigenomics 201801– promoted CFO joined 2010 before Pironet AG + EMI Group Germany) |
Chief Financial Officer (CFO) |
Epigenomics (Group) |
Germany |
| Weber, Barbara (Tango Therapeutics 201804 CEO + Board Member of Revolution Medicines before Novartis) |
Chief Executive Officer (CEO) |
Tango Therapeutics Inc. |
United States (USA) |
| Weber, Christian (ZAR 202404 Managing Director + Co-Founder of ZARWEB GmbH) |
Managing Director |
ZAR (Group) |
Germany |
| Weber, Christoph (Teltow-Fläming (govt) 201005 Division Head Biotechnologiepark Luckenwalde) |
science park |
Teltow-Fläming (county govt) |
Germany |
| Weber, Christophe (Takeda 201504– CEO joined as COO 4/14 before GSK 201305 President GSK Vaccines) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Japan |
| Weber, Corinna (Snap Discovery 202411 CEO) |
Chief Executive Officer (CEO) |
Snap Discovery AG |
Germany |
| Weber, Dirk (Cellestia Biotech 201801 CMO) |
Chief Medical Officer (CMO) |
Cellestia Biotech AG |
Switzerland |
| Weber, Frank (Polyphor 201901– CMDO before InterMune EU + Merck Serono + American Cyanamid/Lederle + Synthelabo + Merck) |
Chief Medical Officer (CMO) |
Spexis (Group) |
Switzerland |
| Weber, Johannes F. (High-Tech Gründerfonds 202309 Senior Investment Manager formerly Bentekk) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Weber, Lutz (OntoChem 200509– before Priaton GmbH) |
Managing Director |
Holtzbrinck (Group) |
Germany |
| Weber, Martin (Qiagen GmbH 200706 also VBU Board Member 200706) |
n. a. |
Qiagen (Group) |
Germany |
| Weber, Matthias G. (Danaher 2012–2019 President of Leica Biosystems) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
Germany |
| Weber, Matthias-Wilbur (Eurofins 200701–201412 CFO died 12/14) |
Chief Financial Officer (CFO) |
Eurofins (Group) |
France |
| Weber, Michael (MCG Motion Capture 201910 Managing Director) |
Managing Director |
MCG Motion Capture GmbH (Motion Capture Group) |
Germany |
| Weber, Moritz (Rittershaus 201511 Lawyer) |
Attorney / Lawyer |
Rittershaus Rechtsanwälte Partnerschaftsgesellschaft mbH |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 88 89 90 ... 94 95 96 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
